#KnowFH #FHAwarenessDay @FamilyHeartFdn @fhpatienteurope @ASPCardio @nationallipid @CiccaroneCenter @NorthwellHealth @BNordestgaard @SethJBaumMD @SethShayMartin @aafp @AANP_NEWS @AAPAorg @HeartNurses @advcardiohealth @AmerAcadPeds @PriMedCME

Familial hypercholesterolemia (FH) is genetic, and it often goes undetected until a serious cardiac event. Early screening, including for children, can protect the whole family. Use the FH SHARED decision-making guide to start the conversation: natforum.org/shared-decision #SDMGuides2026 #KnowFH

Today is #FHAwarenessDay. Familial hypercholesterolaemia (FH) can mean lifelong high LDL cholesterol and increased risk of premature cardiovascular disease. Yet many remain undiagnosed. Earlier diagnosis matters. Proud to contribute to @FH_EARLY and the global FH community.

Check out some of the highlights from the #ASPC2026 Welcome Reception! It was a great way to kick off this year's ASPC congress. #ASPCCongress #ASPC #CVPrevention

Binay Panjiyar, M.D., a #TTUHSC internal medicine resident in Odessa, recently presented multiple posters at @ASPCardio’s Congress on CVD Prevention! He is also a recipient of the Karen and Oak Travel Grant Award and served as Official Social Media Ambassador 2026. #ASPC2026

Privileged and honored to work with this dedicated and talented group of Cardiology Faculty, Fellows and Staff at Houston Methodist DeBakey Heart & Vascular Center.❤️ @HMethodistCV @HMHCardioFellow @ACCinTouch @ASE360 @escardio @SCMRorg @ASPCardio @American_Heart @NYTHealth

For those who missed it, it is not too late to join on demand at times that work for you! You will find our First Women’s Symposium on CVD at @ASPCardio for your viewing pleasure. 💃🏻❤️💃🏻

Now available on demand: the Inaugural Women's Symposium on Cardiovascular Health and Prevention! Join Course Directors @DrMarthaGulati and @DrDastmalchi as they sit down with national experts to discuss updates in women's cardiovascular health. Presenters: @a_l_bailey, Ty Gluckman, MD, MHA, FASPC, @mchonig, @ErinMichos, @AnnMarieNavar, @AnumSaeedMD, @DrMichaelShapir, Leslee Shaw, PhD, @PamTaubMD, @DrKTobb, Watch it here: piped.video/watch?v=-cplfkjc… #ASPC #WomensHealth #CardiovascularHealth #PreventiveHealth

For individuals living with FH or high Lp(a), lipoprotein apheresis can be lifesaving. On #ApheresisAwarenessDay, let’s raise the volume so more people know this treatment exists. Read our blog: familyheart.org/apheresis-aw… #KnowFH #KnowLpa #KnowHoFH #FHAwarenessDay #CholesterolEducationMonth

A clinician may recommend statins even when cholesterol isn’t high. That’s because treatment decisions are based on overall cardiovascular risk, not just one number. Talk with your healthcare team about the next step that makes sense for you. Use the Statin Treatment Planning SHARED decision-making guide to start the conversation: natforum.org/shared-decision #SDMGuides2026 #CholesterolEducationMonth

MHT for Vasomotor Symptoms May Also Offer Cardiovascular Benefits - Thomas Dayspring (@Drlipid) @nationallipid @foundationofnla @society_eas @ASPCardio @MenopauseOrg @TheEndoSociety hemostasistoday.com/science/… #HemostasisToday

📸 A look back at Friday at #ASPC2026 We kicked things off with our Opening Session and Honorary Fellow Award Lecture, then dove into what's new in the guidelines: hypertension, cholesterol, CKM syndrome, and a European perspective on preventive cardiology. The day also brought cutting-edge imaging innovations (hello, AI-enabled risk prediction), a lively Session 4 debate on screening and dyslipidemia guidelines, and a joint session with NLA on novel therapies for Lp(a), inflammation, and beyond. Swipe through for the highlights! 👇 #ASPC2026 #PreventiveCardiology #CardioTwitter

CAC can be effective for risk stratifying individuals with elevated Lp(a). In this study, we ask when to start CAC scoring and when repeat scoring should be considered. @KhedagiApurva @AlexRazavi @rblument1 @MichaelJBlaha @OmarDzaye @AJPCardio @ASPCardio doi.org/10.1016/j.ajpc.2026.…

Kickstarted the weekend with the 1st Annual Symposium on Women’s Cardiovascular Health & Prevention by @ASPCardio 🫀✨ such an inviting and clinically relevant program. A few highlights 👇 🔹 Women with CVD remain under-recognized, undertreated & understudied 🔹 Using PREVENT for 10- & 30-year risk while incorporating sex-specific risk enhancers 📊 🔹 Reproductive history as a window into future CV risk — including premature/early menopause ♀️ 🔹 CAC, coronary plaque imaging & subclinical atherosclerosis help with early detection of underlying risk in women 🫀🖥️ 🔹 The evolving role of PET/CMR in INOCA and coronary microvascular dysfunction 🔬 🔹 Translating plaque burden and risk into earlier, more individualized prevention 🎯 💡 One recurring theme: low short-term calculated risk does not necessarily mean low lifetime cardiovascular risk. A great discussion on moving women’s cardiovascular prevention toward earlier recognition, better phenotyping, and more personalized care ❤️ Thank you to the course directors: @DrMarthaGulati and @DrDastmalchi for this wonderfully curated course!

Thank you for joining us on your Saturday! @ASPCardio #CVPrev #savingwomenshearts

Happy to attend the Women’s Cardiovascular Health and Prevention Virtual Symposium! 🫀 Some takeaways from the early part of the symposium: 🔴 Preeclampsia → 4× HF, 2.5× CAD & 3× stroke risk 🔴 PCOS affects 1 in 8 women and is associated with increased CVD risk 🔴 In WISE, menarche at ≤10 years was associated with a 4.5× higher risk of MACE versus menarche at age 12 🔴 Early menopause (<45 years)—especially premature menopause (<40)—is an important ASCVD risk marker Reproductive history is cardiovascular history. ❤️ #WomensHeartHealth #CardioObstetrics #CardioTwitter @DrDastmalchi @DrMarthaGulati @mchonig @ASPCardio

One of my favorite papers Thanks @kcferdmd @ASPCardio @AJPCardio

Getting ready to start! Check out this program let by @DrMarthaGulati and @DrDastmalchi focusing on #women 💙

Join us live now! We are excited for our first annual virtual conference on women’s CV Health 🫀@ASPCardio #CardioTwitter #CVprev

Heart attack and stroke claim more lives in the U.S. than any other cause. Atherosclerotic cardiovascular disease (ASCVD) is often the reason why. A conversation with a clinician can help lower that risk. Use this guide to start the conversation: natforum.org/shared-decision #SDMGuides2026 #CholesterolEducationMonth